Hiroki Shirato
Overview
Explore the profile of Hiroki Shirato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
377
Citations
7728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, et al.
J Palliat Med
. 2024 Dec;
28(1):42-49.
PMID: 39729365
Utility values of responders and nonresponders are essential inputs in cost-effectiveness studies of radiation therapy for painful bone metastases but, to our knowledge, they have not been reported separately. We...
2.
Utsumi N, Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):140-147.
PMID: 39479804
Objective: Single-center studies or randomized controlled trials have evaluated the impact of radiotherapy for bone metastases on quality of life (QOL). We investigated the real-world impact of radiotherapy for bone...
3.
Harada H, Shikama N, Notsu A, Shirato H, Yamada K, Uezono H, et al.
J Radiat Res
. 2024 Aug;
65(5):701-711.
PMID: 39162649
Purpose of this study is to evaluate patient characteristics, treatments and outcomes in bone metastasis radiotherapy practice. Patients for whom radiotherapy for bone metastasis was planned at 26 institutions in...
4.
Hamada T, Sutherland K, Ishikawa M, Saito J, Miyamoto N, Honma S, et al.
Biochem Biophys Res Commun
. 2024 Jul;
732:150359.
PMID: 39032409
We have previously developed a 3D video tracking system which enables us to analyze long-term quantitative analysis of gene expression in freely moving mice. In the present study, we improved...
5.
Lau B, Wu Y, Cui S, Fu J, Jackson S, Pham D, et al.
Radiother Oncol
. 2024 Apr;
196:110317.
PMID: 38679202
Background And Purpose: Concerns over chest wall toxicity has led to debates on treating tumors adjacent to the chest wall with single-fraction stereotactic ablative radiotherapy (SABR). We performed a secondary...
6.
Nishioka K, Hashimoto T, Mori T, Uchinami Y, Kinoshita R, Katoh N, et al.
Adv Radiat Oncol
. 2024 Apr;
9(5):101464.
PMID: 38560429
Purpose: In real-time image-gated spot-scanning proton therapy (RGPT), the dose distribution is distorted by gold fiducial markers placed in the prostate. Distortion can be suppressed by using small markers and...
7.
Opadele A, Nishioka S, Wu P, Le Q, Shirato H, Nam J, et al.
FEBS Lett
. 2024 Feb;
598(4):446-456.
PMID: 38339784
Whereas extracellular vesicles (EVs) have been engineered for cargo loading, innovative strategies for it can still be developed. Here, we describe domain 4 (D4), a cholesterol-binding domain derived from perfringolysin...
8.
Shirato H
Proc Jpn Acad Ser B Phys Biol Sci
. 2023 Oct;
99(9):389-426.
PMID: 37821390
Biomedical advances of external-beam radiotherapy (EBRT) with improvements in physical accuracy are reviewed. High-precision (±1 mm) three-dimensional radiotherapy (3DRT) can utilize respective therapeutic open doors in the tumor control probability...
9.
Saito T, Shikama N, Takahashi T, Harada H, Ueno S, Notsu A, et al.
Br J Radiol
. 2023 Sep;
96(1151):20230351.
PMID: 37750858
Objective: To identify factors significantly associated with quality of life (QOL) and determine if these associations are strong enough to predict certain aspects of QOL without measuring them. Methods: We...
10.
Gensheimer M, Gee H, Shirato H, Taguchi H, Snyder J, Chin A, et al.
JAMA Oncol
. 2023 Sep;
9(11):1525-1534.
PMID: 37707820
Importance: Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but can cause toxic effects, including life-threatening damage to central structures. Retrospective data suggested that small tumors up to...